| Title: | Association of cardiovascular-kidney-metabolic health and apolipoprotein E4 genotype with risk of dementia and mortality |
| Journal: | Journal of Alzheimer's Disease |
| Published: | 17 Mar 2025 |
| Pubmed: | https://pubmed.ncbi.nlm.nih.gov/40095665/ |
| DOI: | https://doi.org/10.1177/13872877251324093 |
Publication 15578
WARNING: the interactive features of this website use CSS3, which your browser does not support. To use the full features of this website, please update your browser.
Abstract
BackgroundPoor cardiovascular-kidney-metabolic (CKM) health is becoming prevalent; however, sparse data exist regarding the association of CKM health with incident dementia and all-cause mortality.ObjectiveThis study aimed to examine whether poor CKM health is associated with a higher risk of dementia and all-cause mortality, regardless of APOE4 carrier status.MethodsIn this prospective cohort study, 352,364 participants from the UK Biobank were included. CKM syndrome was identified as a medical condition with the presence of metabolic risk factors, cardiovascular disease, and chronic kidney disease, and was classified into five stages (stage 0 to 4). Cox proportional hazards models were applied to explore the association of CKM health with incident dementia and all-cause mortality.ResultsParticipants in stage 2-3 and stage 4 had 1.12-fold (95% CI: 1.02-1.23, p = 0.023) and 2.18-fold (95% CI: 1.96-2.43, p < 0.001) increased risk of incident all-cause dementia compared with those in stage 0. Similarly, participants in stage 4 also had an increased risk of Alzheimer's disease (HR = 1.51, 95% CI: 1.28-1.78, p < 0.001) and vascular dementia (HR = 4.62, 95% CI: 3.54-6.03, p < 0.001). Participants in later stages were at higher risk of all-cause mortality. We found an interaction between CKM health and APOE4 carrier status (p for interaction <0.001), and the relationship between CKM health and dementia was more pronounced in non-APOE4 carriers. Moreover, there were significant additive interactions between APOE4 carrier status and CKM health on the risk of dementia.ConclusionsPoor CKM health is independently associated with an increased risk of dementia, regardless of APOE4 carrier status, and all-cause mortality. These findings imply that promoting CKM health may help to reduce the risk of subsequent dementia and mortality.</p>
15 Keywords
- Aged
- Apolipoprotein E4
- Cardiovascular Diseases
- Cohort Studies
- Dementia
- Female
- Genotype
- Humans
- Male
- Middle Aged
- Mortality
- Prospective Studies
- Renal Insufficiency, Chronic
- Risk Factors
- United Kingdom
7 Authors
- Xinghe Huang
- Jie Liang
- Junyu Zhang
- Jiayi Fu
- Yige Chen
- Wuxiang Xie
- Fanfan Zheng
1 Application
| Application ID | Title |
|---|---|
| 90492 | Identification of risk factors for major chronic diseases among older adults |
Enabling scientific discoveries that improve human health